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Abstract
Mutations in the human Zip4 gene cause acrodermatitis enteropathica, a rare, pseudo-dominant, lethal genetic disorder. We
created a tamoxifen-inducible, enterocyte-specific knockout of this gene in mice which mimics this human disorder. We
found that the enterocyte Zip4 gene in mice is essential throughout life, and loss-of-function of this gene rapidly leads to
wasting and death unless mice are nursed or provided excess dietary zinc. An initial effect of the knockout was the
reprogramming of Paneth cells, which contribute to the intestinal stem cell niche in the crypts. Labile zinc in Paneth cells
was lost, followed by diminished Sox9 (sex determining region Y-box 9) and lysozyme expression, and accumulation of
mucin, which is normally found in goblet cells. This was accompanied by dysplasia of the intestinal crypts and significantly
diminished small intestine cell division, and attenuated mTOR1 activity in villus enterocytes, indicative of increased catabolic
metabolism, and diminished protein synthesis. This was followed by disorganization of the absorptive epithelium. Elemental
analyses of small intestine, liver, and pancreas from Zip4-intestine knockout mice revealed that total zinc was dramatically
and rapidly decreased in these organs whereas iron, manganese, and copper slowly accumulated to high levels in the liver
as the disease progressed. These studies strongly suggest that wasting and lethality in acrodermatitis enteropathica
patients reflects the loss-of-function of the intestine zinc transporter ZIP4, which leads to abnormal Paneth cell gene
expression, disruption of the intestinal stem cell niche, and diminished function of the intestinal mucosa. These changes, in
turn, cause a switch from anabolic to catabolic metabolism and altered homeostasis of several essential metals, which, if
untreated by excess dietary zinc, leads to dramatic weight loss and death.
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Introduction
The rare pseudo-dominant genetic disease acrodermatitis
enteropathica (AE) is thought to be caused by the inefficient
absorption of dietary zinc [1]. AE occurs at a frequency 1 in
500,000 and symptoms in humans usually develop soon after birth
in bottle fed infants or after weaning in breast fed infants. The
triad of alopecia, eczematous dermatitis and diarrhea are classic
symptoms of AE in humans and patients experience growth
retardation and a myriad of symptoms of severe zinc deficiency
which eventually lead to death unless treated by exogenous zinc
[2].
In 2002, the AE gene was mapped to human chromosomal
region 8q24.3 and the Zip4 (Slc39a4) locus [3,4]. Currently, over
32 mutations or variants of ZIP4 have been reported [5]. Missense
and nonsense mutations as well as deletions or rearrangements of
the gene have all been reported, and hypomorphic as well as
complete loss-of-function alleles have been identified.
Recent studies have shed light on the mechanisms of Zip4
regulation and function [6]. Mouse Zip4 is most actively expressed
in tissues involved in the absorption of dietary or maternal zinc,
but also shows high level expression in other cell-types (e.g.
pancreatic islet cells, brain capillaries), and low level expression in
other tissues (e.g. liver, kidney) and some cultured cells. Zip4
expression is regulated by cell-specific transcription as well as by
multiple posttranscriptional mechanisms in response to zinc
availability. ZIP4 protein is at the apical surface of enterocytes
and endoderm cells when zinc is deficient, due to increased
mRNA and protein stability. During zinc deficiency ZIP4
undergoes processing by removal of the extracellular amino-
terminus. In contrast, in the presence of normal levels of zinc Zip4
mRNA is unstable and the protein is internalized and rapidly
degraded.
ZIP4 function is critical during periods of rapid growth when
zinc requirements are high but this zinc transporter also has
important functions when zinc is replete. Zip4 is aberrantly
expressed in many cancers [7,8]. Knockdown of ZIP4 can slow
cell cycle and cell migration in mouse Hepa cells and ZIP4
functions to reduce apoptosis and enhance cell cycle in hepatomas
and to enhance pancreatic tumor growth in nude mice [7,8].
Many recent studies have demonstrated that zinc can modulate
signal transduction cascades [9].
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in Zip4-intestine knockout mice. Homozygous Zip4-intestine
knockout mouse embryos die soon after implantation because this
gene is also actively expressed in the visceral endoderm which
surrounds the developing mouse embryo and which serves a
nutrient uptake function before development of the placenta. The
visceral yolk sac is a more vestigial organ in humans and
apparently contributes little to providing nutrients for the embryo,
explaining why loss of ZIP4 in humans is apparently not
embryonic-lethal. Interestingly, heterozygous Zip4-intestine knock-
out mouse embryos are significantly underrepresented in the
population at parturition. These heterozygous embryos display an
array of developmental defects including exencephalia, anoph-
thalmia, and severe growth retardation. About 22% of the Zip4-
heterozygous mice that survive to weaning age are severely growth
retarded and display anopia, anopthalmia, hydrocephalus and
heart defects, among other abnormalities [10]. Mice heterozygous
for Zip4 knockout are hypersensitive to zinc deficiency. Thus,
haploinsufficiency of Zip4 may contribute to growth retardation in
humans, an effect that is probably exacerbated by zinc deficiency
and/or by modifier genes. Mutations in genes essential for
posttranscriptional regulation of ZIP4 may also cause AE although
this has not been demonstrated. The finding of Zip4 haploinsuffi-
ciency defines AE as a pseudo-autosomal dominant trait.
Given that a global knockout of Zip4 is embryonic lethal in
mice, unlike it is in humans, we sought to develop a better mouse
model of AE. To that end we created mice with floxed Zip4 genes
and bred them with mice that express an ErtCre fusion protein
driven by the villin promoter [11] specifically in intestine
enterocytes. Using this tamoxifen-inducible Zip4-enterocyte knock-
out model we provide evidence that intestine expression of Zip4 is
essential for the growth and viability unless mice are supplied with
excess zinc and that an absence of ZIP4 in the intestine appears to
closely mimic the AE phenotype in humans. Moreover we provide
evidence that an absence of ZIP4 only in the intestine leads to a
rapid switch from anabolic to catabolic metabolism in the animal,
to tissue-specific dysregulation of other essential metals and
alterations in gene expression. These phenotypes appear to reflect
compromised Paneth cell functions which lead to disruption of the
intestinal stem cell niche ultimately resulting in loss of intestinal
integrity and diminished nutrient uptake.
Results
Knocking out the Zip4 gene in the intestinal epithelium
To enable tissue-specific deletion of the mouse Zip4 gene a
targeting construct was created which contained a LoxP site
flanked by an XhoI restriction site in intron 5, and a LoxP site just
downstream of the last exon (exon 12), followed by an mc1-
Neomycin cassette (Figure 1). This construct was targeted in E14
embryonic stem (ES) cells and cells with proper integration of the
floxed Zip4 gene were then identified by long-range PCR using
primers outside of the engineered targeting construct coupled with
overlapping internal primers (Figure 1A). The 59 integration
screen (Figure 1C) amplified a 7.35 kb product from the wild-type
and the floxed alleles and cleavage of the floxed allele with XhoI
yielded the predicted 5.2 and 2.1 kb restriction fragments
indicative of proper insertion of the floxed allele into one of the
endogenous Zip4 alleles. This was confirmed by the 39 integration
screen which yielded a 3.4 kb PCR product from the floxed allele
and a 2.1 kb PCR product from the wild-type allele. Targeted E14
ES cells were used to create chimeric mice by blastocyst injection
and agouti offspring from the chimeric mice were genotyped using
primers which flank the LoxP-XhoI insertion site in intron 5
(Figure 1A). Genotyping PCR yielded a 227 bp product from the
floxed allele, which could be cleaved by XhoI, and a 187 bp
product from the wild-type allele (Figure 1D).
To enable tissue-specific deletion of the floxed Zip4 gene
specifically in the intestinal epithelium, Zip4
FX/FX mice were
crossed with mice that express an estrogen receptor-Cre
recombinase fusion protein under control of the villin promoter
[11]. Vil-Cre-ERT2 is expressed only in the intestinal epithelium
Figure 1. Structures of the pre- and post-Cre floxed mouse Zip4
gene and integration and genotyping screen designs. (A) The
mouse Zip4 gene was captured using gap-repair and then manipulated
using recombineering and the galK selection system. Exons (1–12) are
indicated, as are the positions of LoxP sites (intron 5 and downstream of
exon 12), the mc1-neomycin (MC1-Neo) cassette and the primers used to
screen for integration and genotyping. (B) The structure of the Zip4
gene after Cre recombination is shown. The floxed Zip4 gene was
targeted into E14 ES cells. (C) Properly targeted ES cells were identified
by long range PCR using flanking and internal primers. PCR products
from the control (Con) and floxed (FX) alleles are indicated. XhoI
cleavage was used to differentiate between the floxed and wild-type
alleles in the 59 PCR screen whereas the 39 PCR screen yielded the
predicted larger product from the floxed allele. Targeted ES cells were
used to generate mice homozygous for the floxed Zip4 allele. (D) Mice
were genotyped by PCR amplification of the intron 5 region containing
the LoxP site. The PCR product from homozygous mice before Cre-
induced recombination is shown (left lane). A vil-CreERT2 transgene was
bred into mice homozygous for the floxed Zip4 gene to allow for
tamoxifen induction of Cre activity specifically in the intestinal
epithelium. DNA from the intestine of tamoxifen injected mice was
amplified by PCR to examine the extent of recombination of the floxed
gene (right lane). PCR products from the recombined floxed intestine
allele (intest KO) and the remaining floxed alleles (FX) shown. About 50%
of the cells in the intestine are epithelial which is reflected in the extent
of recombination shown. (E) Northern blot detection of intestine Zip4
mRNA in control (Con) and Zip4-intestine knockout mice (intest KO) 3
days after initiation of the knockout.
doi:10.1371/journal.pgen.1002766.g001
Author Summary
Loss-of-function of the zinc transporter ZIP4 in the mouse
intestine mimics the lethal human disease acrodermatitis
enteropathica. This is a rare disease in humans that is not
well understood. Our studies demonstrate the paramount
importance of ZIP4 in the intestine in this disease and
reveal that a root cause of lethality is disruption of the
intestine stem cell niche and impaired function of the
small intestine. This, in turn, leads to dramatic weight loss
and death unless treated with exogenous zinc.
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the cytoplasm and is driven to the nucleus by tamoxifen which
allows for temporal control of the Zip4 gene deletion [11]. Mice
heterozygous for vil-Cre-ERT2 and homozygous Zip4
FX/FX were
crossed with Zip4
FX/FX mice to yield 50% offspring with Zip4
FX/FX:
vil-Cre-ERT2 alleles and 50% with Zip4
FX/FX alleles. The latter
provided age and genetically matched controls for all of our
experiments and are labeled as control (Con) mice in the figures.
Tamoxifen injections resulted in recombination of approximately
50% of the floxed Zip4 genes in the small intestine of recently
weaned Zip4
FX/FX: vil-Cre-ERT2 mice (Figure 1D: intest KO). This
is as expected since the epithelial cells represent about half of the
cells in the small intestine. The extent of loss of Zip4 mRNA
however provides a suitable assay for the extent of recombination
of the floxed Zip4 gene in the epithelium since the expression of
this gene in the intestine is restricted to the epithelium. Three
injections of tamoxifen resulted in a dramatic, if not complete loss
of intestine Zip4 mRNA (Figure 1E: intest KO) which suggests that
the vast majority, if not all, of the floxed enterocyte Zip4 genes had
undergone recombination. ZIP4 protein in the intestine of mice
fed a zinc-adequate diet is present at only low levels but this
mRNA and protein are stabilized when zinc is deficient. ZIP4
protein and mRNA are rapidly turned-over when dietary zinc is
restored. The loss of Zip4 mRNA is expected to be followed by the
turn-over of ZIP4 protein within a few hours [12].
The intestine Zip4 gene controls growth and viability but
knockout mice can be rescued by nursing or excess
dietary zinc
Symptoms of AE in humans often appear soon after breast
feeding is stopped. Human breast milk provides a rich source of
zinc that is easily absorbed by the gut [13]. The effect of knocking
out intestine Zip4 in neonatal mice (5 days post-partum) was
therefore examined. Newborn mice were injected with tamoxifen
and allowed to suckle until weaning on day 21 post-partum
(Figure 2A). At weaning there was no difference in the average
body weight of the control (7.93 g: n=4) and knockout mice
(7.96 g: n=5) and the intestine knockout mice appeared normal.
However, the Zip4-intestine knockout mice rapidly lost weight
after weaning (Figure 2A and Figure S1A) and perished within a
week unless provided with excess zinc in the drinking water
(Figure 2B). Removal of the excess dietary zinc led to precipitous
weight loss and lethality. Northern blot hybridization confirmed
that the Zip4 gene was effectively knocked out in these neonatal
mice (Figure 2B, inset). Not all of the recently weaned Zip4-
intestine knockout mice thrived after providing excess zinc at
weaning. Those mice could be rescued from lethality for three
weeks post-weaning but failed to gain much body weight during
that period (Figure 2B).
The function of intestine Zip4 in rapidly growing, recently
weaned mice was then examined. Recently weaned mice (5 days
post-weaning) were injected three consecutive days with tamoxifen
and their body weights were measured beginning 1 day after the
first injection (Figure 2C and Figure S1B). These mice continue to
grow for two to three days after the first injection and then begin to
lose weight precipitously. Within a week they lose over 20% of
their body weight although they continue to eat a normal amount
of food and by d8 they can weigh only 60% as much as their
littermate controls (Figure 2D). On day 6 the tibia and quadriceps
muscle from the Zip4-intestine knockout mice weigh 43 to 50%
less than controls while body weight has decreased 23 to 30%
relative to littermate controls (n=4–5; p,0.007). Much of the
weight loss involves loss of muscle and bone mass as has been
reported to occur during dietary zinc deficiency [14]. Thus,
knocking out the intestine Zip4 gene causes a switch from anabolic
to catabolic metabolism in these mice. During the course of these
studies we examined many mice and all of the Zip4-intestine
knockout mice died within two to three weeks. The penetrance of
this phenotype is 100% in both male and female mice.
Northern blot hybridization to small intestine RNA demon-
strated a loss of Zip4 mRNA and a dramatic reduction of Zip5
mRNA (Figure 2C and 2E, insets). ZIP5 is a basolateral zinc
transporter expressed predominately in intestinal crypt cells [15].
This mRNA remains unchanged in abundance during severe zinc
deficiency in mice [15] but its translation is repressed [12] by a
mechanism involving a stem-loop structure in its mRNA [16].
Attenuation of Zip5 mRNA, whose abundance is not responsive to
Zn itself, could suggest injury to the small intestine crypts, as is
shown below.
Excess dietary zinc can ameliorate many of the symptoms of AE
in humans. Therefore, control and Zip4-intestine knockout mice
were provided drinking water containing 250 ppm zinc sulfate
beginning on the day of the first tamoxifen injection (Figure 2E). A
representative animal is shown but 12 mice were analyzed with
similar results. Excess zinc prevented the rapid weight loss in the
Zip4-intestine knockout mice and allowed them to thrive for 4
weeks in this experiment, but withdrawal of the excess zinc led to a
rapid loss of weight and lethality within two weeks. The Zip4 gene
remained knocked out for 4 weeks in these mice (Figure 2E, inset)
which indicates that it was also knocked out in the intestinal stem
cell population, as reported previously using the vil-CreERT2
system [11]. In other experiments it was noted that providing
excess zinc could not effectively ameliorate the lethal effects of the
Zip4 knockout if provided later than day 6 (data not shown).
The efficacy of one, two or three consecutive injections of
tamoxifen on Cre-ERT2 deletion of the Zip4 gene was examined
using recently weaned mice. As described above, three consecutive
injections resulted in effective deletion of the Zip4 gene even in the
intestinal stem cells. In contrast, a single injection of tamoxifen
resulted in partial deletion of the Zip4 gene (Figure 2F, also see
Figure S1C). This did not result in lethality; instead those mice
grew normally for about a week and then began to slowly lose
weight. Thereafter, about half of the mice examined recovered
vigorous growth and grew to adult weight (two are shown in
Figure 2F) while the other half of these mice continued to slowly
lose weight during that time (Figure S1C). The resumption of
vigorous growth coincided with active expression of Zip4 mRNA
which had returned to normal levels by three weeks (Figure 2F,
inset). These data show that partial loss-of-function of ZIP4 can
exert detrimental effects of growth consistent with the findings of
potentially hypomorphic alleles of Zip4 in AE [17] and that
heterozygosity of Zip4 renders mice hypersensitive to zinc
deficiency [10].
Many patients with AE require lifelong zinc supplementation.
Thus, ZIP4 may function not only during periods of rapid growth
but also in full grown adults. Adult mice (7 weeks old) were
injected with tamoxifen and then monitored for changes in body
weight (Figure 2G). The knockout mice began to lose weight
within days of the first injection, lost weight precipitously after 1
week and then succumbed soon thereafter. Thus, the loss of
intestine ZIP4 led to a switch from anabolic to catabolic
metabolism in adult mice.
Loss-of-function of the intestine Zip4 gene has profound
tissue-specific effects on the homeostasis of zinc, iron,
manganese, and copper
ZIP4 is a zinc-specific transporter [18]. Although a recent study
suggests that it may also be able to transport small amounts of free
A Mouse Model of Acrodermatitis Enteropathica
PLoS Genetics | www.plosgenetics.org 3 June 2012 | Volume 8 | Issue 6 | e1002766Figure 2. The intestine Zip4 gene controls growth and viability, but knockout mice can be partially rescued by nursing or excess
dietary zinc. (A) Neonatal mice homozygous for the floxed Zip4 gene and positive for the vil-CreERT2 gene (Zip4 intest KO) and littermates
homozygous for the floxed Zip4 gene but negative for the vil-CreERT2 gene (Con) were injected for 5 consecutive days with tamoxifen beginning 5
days post-partum. After weaning on day 21 their body weights were measured daily (n=5 to 8 mice per group). These mice were fed normal chow
after weaning. Two representative mice from control and Zip4 intestine knock-out mice are shown but all these mice died by day 7 after weaning (see
Figure S1A). (B) Zip4-intestine knockout and control neonatal mice were injected with tamoxifen as in A and at weaning these mice (n=2) were
provided access to drinking water containing excess zinc (ZnE). Their body weight was monitored daily for 2 weeks before removing excess zinc and
continuing to feed normal chow (zinc adequate feed: ZnA). (Blot Inset) Northern blot hybridization was used to monitor Zip4, Zip5 and actin mRNAs in
A Mouse Model of Acrodermatitis Enteropathica
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determined [19]. Herein the effect of knocking out intestine Zip4
in recently weaned mice, on the homeostasis of several essential
metals was examined using ICP-MS. Within 4 days of initiating
the knockout, zinc levels in the small intestine, pancreas and liver
were significantly reduced (Figure 3A) consistent with a primary
function of ZIP4 in the acquisition of dietary zinc. This loss of zinc
correlated temporally with the beginning of precipitous body
weight loss after the knockout. Although, by day 4 a small but
statistically significant loss of copper (Figure 3B) also occurred in
these organs, the largest copper loss was in the small intestine
which also lost ,50% of its iron (Figure 3C). Thus, the loss of
ZIP4 in the intestine led to large reductions in small intestine zinc,
iron and copper content suggesting possible injury to the intestine,
as was found to be the case. An increase in manganese was noted
in the liver (Figure 3D), but no other significant changes in other
elements in these tissues were found on day 4. Remarkably, by day
8 after initiation of the knockout, iron and manganese were twice
as high in the liver of Zip4-intestine knockout mice versus control
and hepatic copper had also increased significantly (Figure 3E). In
contrast, zinc levels were normalized in the liver which suggests
that zinc had been redistributed as body weight declined. The
accumulation of iron in the liver during zinc deficiency has been
reported previously [20,21]. Taken together, these results show
that intestine ZIP4 is essential for the homeostasis of several
essential metals.
Loss-of-function of the intestine Zip4 gene rapidly alters
gene expression in the small intestine
Being able to temporally control the intestine knockout of Zip4
enables us for the first time to monitor the rapid effects of loss-of-
function of a zinc transporter in an animal. This model of AE
compresses the time frame from months in humans to a few days
in mice. This allows for examining primary versus secondary
effects of losing Zip4 function. To that end Northern blot
hybridization and quantitative PCR were used to monitor changes
in Zip4, Zip5 and metallothionein- I (MT-I) mRNAs, zinc homeostatic
genes, in the small intestine (Figure 4). In addition changes in IGF-
1 mRNA, a potent mitogen in the intestine [22], were monitored.
A single injection of tamoxifen resulted in a large loss of native
Zip4 mRNA in the small intestine 24 hr later (Figure 4). By one
day after the second injection (day 2), little or no native Zip4
mRNA was detectable. Zip5 mRNA abundance dropped precip-
itously by day 3 while MT-I mRNA was reduced in abundance
within a day of the first tamoxifen injection but increased again by
d4 and remained high (Figure 4). Thus, deletion of the intestine
Zip4 gene occurs rapidly in this model and leads to significant
changes in the abundance of several mRNAs involved in zinc
homeostasis. The loss of Zip5 expression suggests that injury to the
intestine may occur rapidly after deletion of the Zip4 gene, as Zip5
mRNA abundance is not zinc-responsive.
Deletion of the intestine Zip4 gene led to a large increase in the
abundance of IGF-I mRNA. Several IGF-I transcripts are present
in the intestine. Quantitative PCR of the region encoding IGF-I in
all of the reported transcripts confirmed this Northern blot finding
and established that this mRNA is induced up to 7-fold within a
few days (Figure 4). There were no changes in the abundance of
IGF-I transcripts in control littermates (Figure 4, Con). The Con
blot was over-exposed relative to that of the knockout mice.
Loss-of-function of the intestine Zip4 gene leads to a
rapid loss of Paneth cell zinc, repression of Sox9, and
induction of mucin in Paneth cells, which is accompanied
by disorganization of crypt and villus morphology
Histological examination of the small intestine after Zip4
knockout revealed progressive and profound disorganization of
villus (Figure 5) and crypt architecture (Figure 6) and significantly
diminished cell division within days of the knockout (Figure 7).
Villus histology was apparently normal on day 2 after initiation of
the knockout but became progressively disorganized over the next
4 days (Figure 5A). By day 6 the epithelial cells had lost much of
their columnar morphology with basal nuclei and had become
cuboidal with centric nuclei (Figure 5B). The lamina propria
appeared disorganized, occupied substantially more space in the
villi and often contained red blood cells and cells with pyknotic
nuclei.
Crypts were examined by localizing the transcription factor
Sox9 in sections of small intestine. Sox9 (sex determining region Y-
box9) marks the stem/progenitor cell population in the crypts [23]
as well as the villus enteroendocrine cells [24] and it regulates cell
proliferation and Paneth cell differentiation [25]. In control mice
and Zip4-intestine knockout mice before tamoxifen injections and
on day 2 after initiation of the knockout, Sox9 was localized to the
crypts (Figure 6A) and to dispersed enteroendocrine cells in the
villi (not shown), as reported previously [24]. However, after day 2
the architecture of the crypts progressively became disorganized
and elongated, and Sox9 positive cells were increasingly detected
extending up into the villus epithelium with Sox9 negative cells
interspersed among the positive cells (Figure 6A). By days 4 and 6,
Sox9 negative cells were found at the base of many crypts
(Figure 6A and 6C). The location of these cells at the base of the
crypts suggested that these were Paneth cells; however, these cells
contained large cytoplasmic vacuoles not found in normal Paneth
cells.
Paneth cells contain large amounts of labile zinc which can be
detected by staining with the zinc-specific fluorophore ZP1 [26].
ZP1 staining was readily detectable in the intestinal crypts before
initiation of the Zip4 knockout (Figure 6B). When viewed under
high power ZP1 staining was restricted to one or two cells at the
base of the crypts (Figure 6B; 400X panel) whereas under low
power the fluorescence signal was dispersed throughout the crypt.
ZP1 staining was lost by day 2 after initiation of the knockout and
the neonatal intestine on day 12 post-partum, after the 5th injection of tamoxifen (n=3 mice per group). (C, D, E) Recently weaned mice (Zip4 intest
KO and Con) (n=5 to 7 per group) were injected for 3 consecutive days or (F) injected once with tamoxifen and their body weight was measured
daily. Two representative control and intestine knockout mice are shown. (D) A recently weaned (Con) control mouse (top: 16 g) and a Zip intest KO
mouse (bottom: 9.8 g) were photographed 8 days after initiation of the knockout. Every Zip4-intestine knockout mouse examined died within 16
days of initiation of the knockout. (E) Recently weaned mice (n=12) were provided excess zinc in the drinking water (ZnE) and normal chow
beginning on day 1 after initiation of the knockout. Four weeks later excess zinc was replaced with deionized water and the body weights of the mice
were monitored daily. (Blot Inserts) Northern blot hybridization of intestine RNA isolated on day 7 after initiation of the knockout (C) or on day 10
after removal from excess zinc (E). (F) Intestine RNA was isolated from uninjected mice (O), from mice on day 14 after a single injection of tamoxifen
(1X) or day 21 (1XR) when the mice had recovered growth (n=6 to 10 per group). For comparison intestine RNA from Zip4
FX/FX:vil-CreERT2 mice
injected twice with tamoxifen and harvested on day 4 is shown (2X). (G) Adult Zip4 intest KO and Control littermates (n=2 per group; 7 weeks old)
were injected for 3 consecutive days with tamoxifen and their body weights were measured daily thereafter. The adult Zip4- intestine knockout mice
succumbed on day 9 after initiation of the knockout.
doi:10.1371/journal.pgen.1002766.g002
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PLoS Genetics | www.plosgenetics.org 5 June 2012 | Volume 8 | Issue 6 | e1002766Figure 3. ICP–MS quantification of zinc, iron, manganese, and copper in the small intestine, liver, and pancreas of recently weaned
mice after intestine-specific deletion of the Zip4 gene. Recently weaned mice were injected 3 consecutive days with tamoxifen and the liver
(Liver), pancreas (Panc) and small intestine (Intest) from Zip4-intestine knockout (intest KO) and control (Con) mice (5 to 10 mice per group) were
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rapidly depleted in Paneth cells when ZIP4 function is lost.
The antibacterial enzyme lysozyme is abundantly produced by
Paneth cells [27]. IHC localization of lysozyme in intestine
sections from control and Zip4-intestine knockout mice confirmed
that Paneth cells accumulate large vacuoles, and have reduced
Sox9 and zinc when Zip4 is knocked out (Figure 6C). Paneth cells,
enteroendocrine and goblet cells are thought to arise from a
common precursor [28]. Paneth cells constitute the niche for Lgr5-
positive columnar stem cells in the crypt base [29,30]. The Lgr5-
positive columnar cells can give rise to all epithelial lineages [29].
PAS staining of mucins revealed normal goblet cells interspersed in
the villus epithelium of uninjected and knockout mice (Figure S2).
PAS staining of the small intestine from Zip4-intestine knockout
mice demonstrated positive staining of the large vacuoles in
Paneth cells by day 4 (Figure 6C). This staining was resistant to a-
amylase and was therefore not due to glycogen (data not shown).
Enteroendocrine (Sox9+) cells and goblet (PAS+) cells are long-
lived in the villus epithelium and appeared to be normal in
numbers after knocking out intestine Zip4, at least within the time
period examined (Figure S2). No change in Paneth cells were seen
in control littermates (Con) that had been similarly injected with
tamoxifen and processed in parallel (data not shown). These results
indicate that loss-of-function of intestine ZIP4 leads to a rapid loss
of Paneth cell zinc which is followed by changes in Paneth cell
morphology and phenotypic reprogramming.
Loss-of-function of the intestine Zip4 gene leads to
repressed cell division
The relative amount of cell division in the small intestine was
determined since Sox9 plays a role in intestinal stem cell
proliferation and the crypts are critical for renewal of the
epithelium. Cell division was monitored by IHC for phosphory-
lated (Ser 10) histone H3 and quantified by counting positively
stained cells in multiple fields of view (5 or more) in sections from
several (4 or 5 mice) control and Zip4-intestine knockout mice
(Figure 7). On day 2 after initiation of the knockout, cell division
was measurably repressed (22%) in the small intestine and by day
4, cell division was reduced by 47% and remained repressed on
day 6. No reduction in cell division after tamoxifen injections was
noted in control littermates (data not shown). These results reveal
that intestine ZIP4 functions to maintain the structural and
functional integrity of the small intestine.
Loss-of-function of the intestine Zip4 gene causes a rapid
loss of phosphorylated S6 ribosomal protein in the villus
epithelium followed by increased phosphorylated S6
ribosomal protein in the crypts
Given the repressive effects of loss-of-function of ZIP4 on small
intestine cell division and structural integrity leading to a switch
from anabolic to catabolic metabolism in mice, we examined the
effects of this knockout on the activity of mammalian target of
rapamycin (mTOR1) in the intestine. mTOR1 plays an important
role in growth regulation and intestinal cell migration by
integrating signals from nutrients, energy status, growth factors
and stresses thereby controlling protein translation [31–33].
Ribosomal protein S6 kinase is activated by mTOR1 leading to
phosphorylation of ribosomal protein S6 and enhanced translation
[31]. Therefore, the status of phosphorylated ribosomal protein S6
was monitored by IHC in the small intestine of control and Zip4-
intestine knockout mice (Figure 8). Phosphorylated ribosomal
protein S6 was readily detectable in the enterocytes of the villus
tips in control mice. Little or no staining was detected in crypts
(Figure 8A). However, by d2 after initiating the knockout staining
in the crypts became apparent while that in the villus tips was
diminished (Figure 8B), and by d4 crypt staining was strong and
villus staining was weak or absent. On day 6 crypt staining
remained strong and cells interspersed in the villus epithelium
stained positive for phosphorylated ribosomal S6 protein. Closer
examination of the stained crypts revealed an absence of staining
in the Paneth cells (Figure 8B). These results indicate that loss of
ZIP4 function in enterocytes leads to a rapid and prolonged
diminution in mTOR1 activity and impaired protein synthesis in
those cells. Remarkably this is accompanied by enhanced mTOR1
activity in the stem cell niche, but not in Paneth cells.
Loss-of-function of the intestine Zip4 gene causes rapid
and transient changes in energy metabolism in the liver
Unlike the intestine, the liver in Zip4 intestine knockout mice
apparently does not undergo obvious morphological changes and
the liver to body weight ratio remains relatively constant during
the first week or so after initiating the knockout (data not shown).
In contrast there is a rapid loss of bone and muscle mass and body
harvested. Values for zinc (A), copper (B), iron (C) and manganese (D) on day 4 after initiation of the knockout. (E) Values for liver metal concentrations
on day 8 after initiation of the knockout. Individual tissue samples were analyzed by ICP-MS for multiple elements including the essential metals. Data
are expressed as ppm for each metal 6 S.E.M. Statistical significance was determined using the Unpaired T-test (two-tailed). Values were considered
different if P,0.05. *indicates P,0.05; *** indicates P,0.001; **** indicates P,0.0001.
doi:10.1371/journal.pgen.1002766.g003
Figure 4. Northern blot analysis of temporal changes in small
intestine gene expression after intestine-specific deletion of
Zip4. Recently weaned mice were injected 3 consecutive days with
tamoxifen and the small intestines from Zip4-intestine knockout (Zip4
intest KO) and control (Con) mice (3 mice per group) were harvested on
the indicated days after initiation of the knockout and analyzed for Zip4,
Zip5, IGF-1 and actin mRNAs by Northern blotting. IGF-1 has multiple
transcripts and the control blot is over-exposed relative to the Zip4-
intestine blot. IGF-1 transcripts in the Zip4-intestine knockout intestine
were also quantified by qPCR using primers which amplify the active
IGF-1 peptide encoding region of all IGF-1 transcripts. The fold change
in IGF-1 mRNA relative to day 1 is presented below the autoradiograph.
doi:10.1371/journal.pgen.1002766.g004
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therefore, the status of AMP-activated protein kinase (AMPK) and
mTOR1 activity in the liver were examined by Western blotting
(Figure 9). The activity of AMPK is allosterically increased by
AMP binding which leads to phosphorylation and activation of
AMPK. When ATP generation is attenuated, AMPK becomes
activated and phosphorylates many substrates leading to increased
activation of catabolic pathways and reduced activation of
anabolic pathways [32]. As mentioned above, mTOR1 activity
enhances anabolic metabolism by supporting translation and
transcription.
Western blot analysis of liver proteins revealed that phosphor-
ylated (T172)-AMPK increased soon after the knockout of
intestine Zip4 reaching a peak on day 3 before rapidly declining
(Figure 9). This decline was accompanied by increased and
prolonged phosphorylation (S2448) of mTOR1. In contrast, little
change was noted in the phosphorylation of AKT (S473) or active
b-catenin until day 8. Taken together, these results show that the
loss-of-function of intestine ZIP4 rapidly causes a switch from
anabolic to catabolic metabolism in the liver reflecting an
increased AMP/ATP ratio. However, this effect was transient
and mTOR1 activity was restored when the mice began wasting
muscle and bone which would provide amino acids and other
energy sources for liver metabolism. Thus, unlike the small
intestine (as well as bone and muscle) the liver is only transiently
affected by the loss-of-function of intestine ZIP4.
Discussion
Herein we describe the creation of a mouse model of the rare
pseudo-dominant human genetic disorder of zinc metabolism AE.
Being able to control the timing and extent of the knockout of
enterocyte Zip4 in mice, and the rapid progression of the disease
thereafter, allowed us for the first time to effectively address
underlying mechanisms of AE. A central remaining question in
our understanding of AE has been to define the role of intestinal
Zip4 in the etiology of this disease. Mouse Zip4 expression can be
detected in several cell-types [18,34]. Human Zip4 expression is
also detected in several organs (NCBI Unigene EST profile) and
fibroblasts from AE patients show diminished zinc uptake and zinc
content leading to the suggestion that loss-of-function of ZIP4 in
organs other than the intestine could contribute to the pathology
of AE [35]. Our data demonstrate that the most profound
phenotypes of AE, severe growth retardation and morbidity,
reflect a loss-of-function of ZIP4 only in intestinal enterocytes, that
was predicted from studies of patients with AE nearly 30 years ago
[2]. A significant difference between this mouse model and human
AE is the lack of severe dermatitis and alopecia in mice. This likely
reflects the fact that Zip4 is actively expressed in human skin
(NCBI Unigene EST profile) whereas it is not actively expressed in
mouse skin [18].
In mice, growth retardation and/or weight loss occur rapidly
after enterocyte Zip4 is knocked out and the disease progresses to
morbidity within a few days accompanied by a switch from
anabolic to catabolic metabolism, unless mice were nursing or
given access to high zinc concentrations in their water. Similarly,
humans with AE respond favorably to increased dietary intake of
zinc. How zinc is absorbed from the gut in the absence of ZIP4 is
not known. However, uptake of zinc by L-type calcium channels
has been reported [36] and several other Zip and ZnT proteins are
expressed in the intestine and could contribute to zinc uptake
when zinc levels are very high [37–39].
Our studies revealed that one of the most rapid effects of loss-of-
function of intestine ZIP4 is the loss of labile zinc from Paneth
cells. This may therefore be an initial event in the progression of
AE. Studies of patients with AE, also reported nearly 35 years ago,
revealed changes in Paneth cells including the accumulation of
abnormal inclusion bodies and giant granules, which were
reversed when patients were given oral zinc [40–42]. Zinc
deficiency or prolonged fasting has been shown to cause the loss
of Paneth cell zinc, as measured by reactivity with the zinc chelator
dithizone [43] and dithizone injection causes selective killing of
Paneth cells [44]. However, zinc deficiency alone in rats does not
lead to abnormal Paneth cell morphology [45] which suggests that
Figure 5. Progressive disruption of villus integrity after intestine-specific deletion of Zip4. Recently weaned mice were injected 3
consecutive days with tamoxifen and the small intestines from control (Con) and Zip4-intestine knockout (Zip4 intest KO) mice (5 mice per group)
were harvested on the indicated days after initiation of the knockout. (A) Sections of small intestine were stained with hematoxylin-eosin. Sections
from control day 0 and day 6 intestine are shown (2 left side panels), whereas sections from Zip4-intestine knockout days 2–4 and day 6 intestine are
shown (4 right side panels). (B) A blow-up view of the Zip-intestine knockout d6. Black arrowheads demarcate examples of cubodial epithelial cells
and RBCs in the lamina propria.
doi:10.1371/journal.pgen.1002766.g005
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reprogramming of Paneth cells. Recently weaned mice were injected 3 consecutive days with tamoxifen and the small intestines from Zip4-
intestine knockout (Zip4 intest KO) and control (Con) mice (5 mice per group) were harvested on the indicated days after initiation of the knockout.
(A) Paraffin sections of small intestine were processed for IHC using an antibody against mouse Sox9. Brown color indicates positive immunostaining.
Bars below the d2 and d6 panels of Zip4 -intestine knockout section demarcate the approximate length of the crypts in each panel and black
arrowheads indicate Sox9 negative cells interspersed among the positive cells (d2) and Sox9 negative cells at the base of the crypts (d6). (B) Frozen
sections of small intestine from Zip4-intestine knockout mice were incubated with ZP1 and photographed using the GFP cube. Brightness of the
sections was reduced equally in Photoshop. Green indicates positive signal for zinc-induced ZP1 fluorescence. A higher power view of the red boxed
region in the d0 panel is shown below and white arrows demarcate labeled Paneth cells. (C) Paraffin sections were processed for IHC using an
antibody against mouse Sox9 or lysozyme. Brown color indicates positive immunostaining. Serial sections were also stained with PAS to detected
mucin. Dark pink to red color indicates positive PAS staining. Black arrows demarcate Paneth cells in the d6 Sox9 stained panel. Tamoxifen injections
did not affect Sox9, lysozyme or mucin staining of small intestine sections from control littermates (not shown).
doi:10.1371/journal.pgen.1002766.g006
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Paneth cells in AE patients.
The loss-of-function of intestine ZIP4 rapidly alters the
phenotype of Paneth cells which are long-lived, suggesting that
preexisting Paneth cells undergo reprogramming. The rapid loss of
zinc in these cells is followed by reduction of Sox9 and the
accumulation of mucin positive Paneth cells. Sox9 regulates cell
proliferation in the small intestine epithelium as well as Paneth cell
differentiation and repression of mucin (Muc2) expression [23,46].
Sox9 is regulated by the Wnt pathway [23] which suggests that
ZIP4 may play a role in regulating signal transduction in Paneth
cells via the Wnt-APC pathway. A role of zinc in controlling
glycogen-synthase kinase-3b (GSK-3b) activity and, by extension
the Wnt-APC pathway, has been reported [47–49]. Increased zinc
leads to increased phosphorylation of GSK-3b, the accumulation
of b-catenin and increased signal transduction. Therefore, our
data are consistent with the concept that the loss of zinc in Paneth
cells leads to reduced phosphorylation of GSK-3b, increased turn-
over of b-catenin, reduced Sox9 expression, and reprogramming
of crypt Paneth cells.
Loss-of-function of ZIP4 also resulted in a reduction in cell
division in the crypts which may be a consequence of the altered
Paneth cell phenotype and crypt dysplasia. A recent report
revealed that Paneth cells contribute to the intestinal stem cell
niches by expressing several growth factors, most importantly Wnt,
which support those stem cells [30]. Perturbed function of Paneth
cells would negatively affect Lgr5 columnar stem cells which are
interspersed between Paneth cells in the crypts [29,30]. These
stem cells are able to give rise to all the epithelial lineages in vivo,
can generate crypt like structures in vitro, and there is a strong
correlation between the number of Paneth cells and the number of
Lgr5 stem cells in the intestine in vivo [29,30]. Therefore, impaired
Paneth cell function contributes to reduced cell division in the
small intestine through its effects on the stem cell niche.
It is interesting to note that Zip4 expression in the mouse
intestine is restricted to villus enterocytes and this protein is not
detected by IHC in the crypts [15,18]. Although this cannot
exclude the possibility that weak expression of Zip4 in the crypts
may contribute to the changes noted in Paneth cells after this gene
is knocked out, a more plausible explanation is that loss-of-
function of villus enterocyte ZIP4 leads to loss of Paneth cell zinc
and it is this loss of zinc which initiates the reprogramming of
Figure 7. Quantification of phosphorylated-histone H3 labeled
cells in sections of small intestine after intestine-specific
deletion of Zip4. Recently weaned mice were injected 3 consecutive
days with tamoxifen and the small intestines from Zip4-intestine
knockout mice (5 mice per group) were harvested on the indicated day
after initiation of the knockout. Paraffin sections were processed for IHC
using an antibody against Ser 10 phosphorylated-histone H3. The
number of positive cells per field of view was counted in multiple
sections from several mice and the values shown are the mean 6 S.E.M.
Statistical significance was determined using the Unpaired T-test (two-
tailed). Values were considered different if P,0.05. *indicates P,0.05;
**** indicates P,0.0001. Tamoxifen injections did not affect phospho-
H3 labeling in small intestine sections from control littermates (not
shown).
doi:10.1371/journal.pgen.1002766.g007
Figure 8. IHC detection of phosphorylated S6 ribosomal protein, as a read out for mTOR1 activity, reveals a loss of villus staining
followed by increased staining of crypts after intestine-specific deletion of Zip4. Recently weaned mice were injected 3 consecutive days
with tamoxifen and the small intestines from Zip4-intestine knockout mice (5 per group) were harvested on the indicated days after initiation of the
knockout. (A) Paraffin sections were processed for IHC using an antibody against mouse phospho-S6 ribosomal protein. Brown color indicates
positive immunostaining. (B) High power views of panels in (A). Black arrows demarcate Paneth cells. Tamoxifen injections did not affect phospho-S6
ribosomal protein staining in sections of small intestine from control littermates (not shown).
doi:10.1371/journal.pgen.1002766.g008
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function of ZIP4 in Paneth cells. The blood circulation provides an
intimate connection between the villus and crypt such that
enterocyte absorbed nutrients, including Zn, are available at high
concentrations to cells in the crypt.
There is evidence for zinc transporters affecting cell signaling.
Studies of knockout mice suggest that Slc39a14 (ZIP 14) represses
phosphodiesterase activity leading to enhanced systemic growth,
but the loss-of-function of ZIP14 is not lethal and has only modest
effects on growth [50], unlike the loss of ZIP4 function. Similarly
Slc39a13 (ZIP 13) has been shown to play a role in connective
tissue development where it affects BMP/TGF-b signaling [51].
The preponderance of data suggests that zinc mediates the effects
of these zinc transporters [9]. However, ZnT1 has been shown to
directly interact with EVER proteins [52] leading to altered
intracellular distribution of zinc, and ZnT1 can interact with Raf-1
kinase through its c-terminal domain leading to activation of ERK
signaling [53]. No binding partners of ZIP4 have been reported.
In contrast to the pattern of Zip4 expression in villi, Zip5
expression is most active in crypt cells where it localizes to the
basolateral membrane when dietary zinc is adequate [15]. This
protein is normally degraded during periods of zinc deficiency but
the mRNA stays associated with polysomes [12] and its translation
is regulated by a conserved stem-loop structure in the 59-
untranslated region and two microRNAs in response to zinc
[16]. The reduction of Zip5 mRNA abundance after knocking out
the enterocyte Zip4 gene occurs concomitantly with crypt
dysplasia. However, intestine-specific knockout of mouse Zip5 is
asymptomatic (Geiser and Andrews, unpublished results) which
suggests that loss of Zip5 expression in the crypts of the Zip4-
intestine knockout mice reflects a loss of the differentiated state of
intestinal crypt cells.
Another rapid effect of loss-of-function of intestine ZIP4 is the
attenuation of mTOR1 activity, as measured by phosphorylation
of S6 ribosomal protein, in the villus epithelium. This indicates
that protein synthesis in villus enterocytes is rapidly diminished
after ZIP4 is lost [31]. The intestine has a high rate of protein
synthesis to supply digestive enzymes and transporters necessary
for enterocyte nutritional functions, and total intestine utilization
of amino acids can account for half of whole-body utilization [54].
Attenuation of protein synthesis in the intestine impairs growth via
malnutrition. For example, the loss-of-function of intestine
Slc6a19, the neutral amino acid transporter, impairs growth and
body weight control in mice and reduces mTOR1 activity in the
intestine [55] but is not lethal. Whether loss-of-function of ZIP4
attenuates amino acid uptake by the small intestine remains to be
determined but amino acids and growth factors play essential roles
in mTOR1 signaling [31] and amino acid stimulation of mTOR1
signaling and protein synthesis are required for intestinal cell
migration [33]. The attenuation of mTOR1 activity in villus
enterocytes likely contributes to the disorganization of the
epithelium which occurs after Zip4 is knocked out. Dietary zinc
enhances mTOR1 signaling and GSK-3b phosphorylation in
skeletal muscle and liver leading to increased protein synthesis
[49]. Similar to Paneth cells, villous enterocytes show altered
morphology when intestine Zip4 is knocked out. Combined with
the reduced rate of cell division and reduced mTOR1 activity, the
loss of normal columnar morphology of enterocytes is consistent
with a loss of differentiated function, which likely is a major
contributor to growth failure in these mice.
Our studies revealed that loss-of-function of intestine ZIP4 leads
to transient activation of hepatic AMPK, a cellular energy sensor
which is activated when AMP levels increase [32] and which
antagonizes mTOR1 activity [32]. Loss of zinc likely leads to
attenuated mTOR1 signaling in the liver through reduced
production of ATP and activation of AMPK. This is followed by
repletion of hepatic zinc due to the redistribution of zinc, and
other nutrients, from bone and muscle stores as the knockout mice
begin to lose body mass. This leads to attenuation of AMPK
activity and increased mTOR1 activity. By extension, the
attenuation of villous mTOR1 activity in response to the loss-of-
function of ZIP4 in villous enterocytes likely reflects a response to
diminished zinc uptake rather than a signaling function of the
ZIP4 protein in enterocytes.
In addition to the potential reduction in intestinal uptake of
amino acids and zinc which can control mTOR1 activity, it is also
possible that loss-of-function of ZIP4 attenuates IGF-1 signaling in
the intestine. Intestine IGF-1 mRNA is induced after Zip4 is
knocked out and this growth factor is a potent tropic mitogen in
the intestine [22]. IGF-1 mRNA is induced in intestinal
subepithelial myofibroblasts in response to stimulation by gluca-
gon-like-peptide 2 secreted from intestinal L-cells, and IGF-1
enhances crypt cell proliferation by stimulating b-catenin signaling
in non-Paneth cells [22]. The finding that IGF-1 is induced but
mTOR1 activity is repressed in the villus epithelium suggests that
IGF-1 signaling is attenuated when intestine ZIP4 is lost.
Intracellular zinc concentrations have been shown to modulate
IGF-1 signaling by affecting protein tyrosine phosphatase activity
[56]. High zinc is inhibitory leading to enhanced IGF-1 signaling
whereas zinc deficiency impairs IGF-1 signaling [57].
Loss of mTOR1 activity in the villus epithelium occurred soon
after Zip4 was knocked out in the intestine. In contrast, the activity
Figure 9. Western blot analysis of phosphorylated and total
AMPKa, mTOR1, AKT, and b-catenin in the liver after intestine-
specific deletion of Zip4. Recently weaned mice homozygous for the
floxed Zip4 gene and positive for the vil-CreERT2 gene (Zip4 intest KO)
and littermates homozygous for the floxed Zip4 gene but negative for
the vil-CreERT2 gene (Con) were injected for 3 consecutive days with
tamoxifen. Livers were harvested on the indicated day after initiation of
the knockout and pooled from 3 to 5 mice per group. Soluble proteins
were analyzed by Western blotting using the indicated antibodies. Black
stars in the WT p-(S2448)- mTOR blot indicate samples that were
partially degraded. mTOR1 is a 289 kDa protein.
doi:10.1371/journal.pgen.1002766.g009
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to enhanced cell proliferation. The activation of mTOR1 in crypts
may reflect a stress response or a compensatory response to crypt
dysplasia in the intestine [32]. Increased IGF-1 signaling may lead
to activation of mTOR1 in crypt cells causing enhanced translation
butfailstoenhancecelldivisionduetoimpairedb-cateninsignaling.
Clearly a complicated interplay between loss of zinc and altered
signal transduction cascades occurs in the intestine leading to
diminished integrity of the small intestine in AE.
Loss-of-function of intestine ZIP4 led to altered homeostasis of
several essential metals over time. Although zinc was rapidly lost
from intestine, pancreas and liver soon after the Zip4 knockout,
normal levels of zinc re-accumulated in the liver as body weight,
bone and muscle mass were lost. In contrast, iron and manganese
accumulated in the liver. Accumulation of iron in the liver during
zinc deficiency has been previously reported but manganese
accumulation has not. Zinc deficiency can result in alterations in
iron transporter, storage, and regulatory proteins which facilitate
iron accumulation [20]. In addition ZIP14 (Slc39a14) has been
suggestedtoplayaroleintheaccumulationofnon-transferrinbound
iron in the liver [58]. It is possible that reduced expression of
ATP13A2, which has been shown to reduce cellular manganese
concentrations, occurs in response to severe zinc deficiency in our
model [59], and a recent study revealed that ZnT10 (Slc30a10) plays
a key role in manganese transport in humans [60,61]. Whether
enhanced expression or activity of ZIP14 and/or repression of
ZnT10 play roles in the accumulation of iron and manganese,
respectively, in the liver in response to loss-of-function of intestine
ZIP4 remains to be determined. Accumulation of very high levels of
iron in the liver (20 to 1006) can lead to hemochromatosis and can
inhibit manganese uptake by mitochondria leading to mitochondrial
dysfunction [62]. Therefore, the slow accumulation of hepatic iron
and manganese in the Zip4-intestine knockout mice could eventually
contribute to liver injury if very high levels are accumulated later
during the disease process. Perhaps humans with AE may be at risk
for hemochromatosis at advanced stages of the disease.
In summary, our studies report the first conditional knockout of
a member of the mammalian ZIP family of zinc transporters. By
controlling the timing and extent of the knockout of the intestine
Zip4 gene in mice we were able for the first time to monitor
temporal and tissue-specific effects of the loss-of-function of ZIP4
and provide insights into the etiology of AE. The results suggest
that Paneth cell dysfunction leading to disruption of the stem cell
niche and loss of villus enterocyte integrity are primary causes of
AE. These changes likely reflect diminished zinc uptake by ZIP4
and are followed by a switch from anabolic to catabolic
metabolism in the mouse leading to dramatic weight loss,
dyshomeostasis of several essential metals and ultimately lethality
in the absence of excess dietary zinc.
Materials and Methods
Animals
Experiments involving mice were performed in accordance with
the guidelines from the National Institutes of Health for the care
and use of animals and were approved by the Institutional Animal
Care and Use Committee. Mice were maintained on normal
mouse chow (zinc adequate:ZnA) and where indicated were also
provided with drinking water containing 250 ppm ZnSO4 (zinc
excess: ZnE).
Recombineering of a floxed Zip4 (Slc39a4) gene
We previously described the structure of the mouse Zip4
(Slc39a4) gene in detail [15,18]. The final structure of the floxed
Zip4 gene targeting vector created herein and of the targeted
chromosomal locus is shown in Figure 1. BAC recombineering
[63] using galK selection was employed to manipulate the Zip4
gene [64] A 9180 bp region containing the Zip4 gene plus 2.3 kb
of 59-flanking DNA and 3.2 kb of 39 flanking DNA was captured
from BAC ct7-43303 and gap-repaired in a conditionally
amplifiable [65] BAC-based vector (P[acman]-M-KO) [66] that
allows for negative selection (HSV-TK) in ES cells and positive
selection in bacteria (ampicillin). A LoxP site engineered to contain
an Xho I restriction site was inserted into a poorly conserved region
in intron 5 and a second LoxP site was inserted immediately
downstream of exon 12, the last exon in this gene. An mc1-neomycin
cassette was inserted about 250 bp downstream of exon 12. The
targeting vector’s structure was confirmed for the entire gene
including the neomycin cassette by DNA sequencing and the ends
of the captured regions were sequenced to verify that no
rearrangements or mutations had occurred. In addition, the
functionality of the LoxP sites was confirmed by transformation of
the final targeting vector into bacteria (EL 350) that express Cre
recombinase under control of an arabinose inducible promoter
[63].
Targeted insertion of the floxed Zip4 (Slc39a4) gene in
embryonic stem cells
The Transgenic and Gene-Targeting Institutional Facility at the
KU Medical Center generated targeted ES cell clones and
performed blastocyst injections. The Zip4
FX targeting vector was
linearized with Not1 and electroporated into E14 embryonic stem
(ES) cells. Selected colonies were screened by long range PCR
using LA-Taq (TaKaRa Bio, Inc.) and primers which flank the
Zip4 region captured and manipulated by recombineering paired
with primers within the Zip4 gene itself (Figure 1). Primers flanking
the LoxP site in intron 5 were used for routine genotyping of the
targeted allele in mice (Figure 1). Homologous recombination of
the targeting vector into the endogenous locus resulted in the
insertion of an XhoI site engineered into the LoxP sequence in
intron 5 which aided in identifying the targeted alleles. Southern
blot hybridization was used to screen for the Y-chromosome as
described in detail previously [67]. The sequences of oligonucle-
otides for integration screen and genotyping are shown in Table
S1.
Generation of mice with targeted floxed Zip4 (Slc39a4)
alleles
Chimeric mice were generated by microinjection of two
independent Zip4
FX/WT ES cell clones into d4 C57BL/6
blastocysts, followed by transfer to pseudopregnant CD-1 foster
mothers. Resulting chimeric mice were crossed with C57BL/6
females (Harlan labs). Germline transmission was confirmed by
PCR from tail DNA of agouti offspring (Figure 1). Zip4
FX/WT mice
were crossed and Zip4
FX/FX offspring were identified by PCR
amplification of the LoxP:XhoI insertion in intron 5.
Generation of mice for inducible deletion of Zip4
FX/FX
(Slc39a4) alleles in the intestinal epithelium
Zip4
FX/FX mice were crossed to create a working colony of mice
homozygous for floxed Zip4 genes. These mice were then crossed
with transgenic mice bearing a tamoxifen-dependent Cre
recombinase (vil-Cre-ERT2: a kind gift from S. Robine, Institut
Curie-CNRS, Paris, France) expressed under the control of the
villin promoter to allow for inducible deletion of the Zip4 gene
specifically in the intestinal epithelium [11] and selected offspring
were backcrossed to yield mice heterozygous for vil-Cre-ERT2 and
A Mouse Model of Acrodermatitis Enteropathica
PLoS Genetics | www.plosgenetics.org 12 June 2012 | Volume 8 | Issue 6 | e1002766homozygous Zip4
FX/FX. These mice were then crossed with
Zip4
FX/FX mice to yield 50% offspring with Zip4
FX/FX: vil-Cre-
ERT2 alleles and 50% with Zip4
FX/FX alleles. The latter provided
age and genetically matched controls for our experiments and
were labeled as control (Con) in all the figures.
Tamoxifen induction of recombination
A tamoxifen stock solution was prepared essentially as described
previously [68] by the addition of 100 ml of ethanol to 10 mg of
tamoxifen (free base: MP biomedicals, LLC) and heating to 37uC
briefly to dissolve the tamoxifen. This solution was then diluted to
1 ml with autoclaved canola oil and heated briefly to 37uC. The
stock solution (10 mg tamoxifen/ml) was stored at 4uC for up to
two weeks or at 280uC for months. Before injection, the
tamoxifen stock solution was heated to 37uC. Adult and recently
weaned mice (5 to 8 days post-weaning) were injected I.P. with
100 ml (1 mg tamoxifen) of the tamoxifen stock solution daily for 3
consecutive days unless noted otherwise (e.g. Figure 2F). Neonatal
mice (d5 post-partum) were injected I.P. for 5 consecutive days
with 10 ml (100 mg) of the tamoxifen stock solution.
Northern blot hybridization
Total RNA was isolated using Trizol reagent (Invitrogen). Total
RNA (3–6 mg) was size-fractionated by agarose-formaldehyde gel
electrophoresis, transferred and UV cross-linked to a Zeta Probe
GT nylon membrane (BioRad). Northern blot membranes were
prehybridized in 0.5 M sodium phosphate, pH 7.0, 7% SDS at
65uC for 30 min and then hybridized in 40% formamide, 0.5 M
sodium phosphate, pH 7.0, 7% SDS at 65uC for 24 hr.
Membranes were then washed twice in 3X SSC, 0.1% SDS for
30 min each followed by two washes in 1X SSC, 0.1% SDS and
two washes in 0.3X SSC, 0.1% SDS for 30 min each at 65uC.
Hybrids were detected by autoradiography at 280uC. Duplicate
gels were stained with acridine orange to ensure equivalent loading
and integrity of total RNA. Riboprobes for mouse MT-I, Zip4, and
Zip5 [15] and for IGF-1 mRNAs were as described [69]. Probes
were used at 2610
6 cpm/ml of hybridization solution.
Quantitative RT–PCR of IGF-1 mRNA
Small intestine total RNA was reverse transcribed using
Accuscript reverse transcriptase (RT) enzyme (Stratagene) and
IGF mRNA and GAPDH mRNA, as an internal control, were
amplified using the PerfeCTa Sybr Green FastMix qPCR kit
(Quanta Biosciences) and a Miniopticon Real-Time PCR Detec-
tion System (BioRad) essentially as described previously [8].
Melting-curve data were collected to confirm PCR specificity.
Each cDNA sample was run in triplicate, and the corresponding
no-RT sample was included as a negative control. GAPDH primers
were included in every sample to control for sample variation.
IGF-1 mRNA product in each sample was normalized to that of
the GAPDH mRNA. The amount of PCR products was measured
by threshold cycle (Ct) values and relative mRNA levels were
determined as unit values of 2‘[Ct(GAPDH) -Ct(IGF-1)]. Values
presented are fold-change relative to control. The following
primers were used: mIGF-1 (s) gctcttcagttcgtgtgtggaccg: mIGF-1
(as) cttctgagtcttgggcatgtcagtgtg. These primers amplify the IGF-1
peptide sequence found in all mIGF-1 variants. GAPDH (s):
aggttgtctcctgcgacttca: mGAPDH (as) ccaggaaatgagcttgacaaag.
Antisera
The following antibodies were used at the indicated dilution for
Western blots: Total b-catenin (Cell Signaling: 1:1000), active b-
catenin (Millipore: 1:1000), p(T172)-AMPK (Cell Signaling:
1:1000), total AMPK (Cell Signaling: 1:1000), p(S2448) mTOR1
(Cell Signaling: 1:1000), total mTOR1 (Cell Signaling: 1:1000),
p(s473)-AKT (Cell Signaling: 1:1000), total AKT (Cell Signaling:
1:1000). The following antibodies were used at the indicated
dilution for immunohistochemistry (IHC): Sox9 (Millipore: 1:750),
lysozyme (DakoCytomation: 1:150), phospho-S6 ribosomal pro-
tein (Cell Signaling: 1:400), phosphor (Ser10)-histone H3, (Cell
Signaling: 1:100)
Histology/cytochemistry/immunohistochemistry (IHC)
The first ,5 cm of small intestine (3 to 5 mice per group) was
collected, flushed with cold PBS, cut into small pieces and fixed in
Bouin’s fixative or 4% paraformaldehyde in PBS overnight at 4uC.
Fixed tissues were embedded in paraffin and sections (1 mm) were
prepared by Histo-Scientific Research Laboratories (HSRL).
Bouin’s fixed sections were deparaffinized, rehydrated and stained
with hematoxylin-eosin for examination of gross morphology.
Paraformaldehyde fixed tissues were deparaffinized, rehydrated
and stained using the Periodic Acid-Schiff (PAS) staining system
(Sigma-Aldrich) to detect mucin (mainly Muc2 and Muc3) and
identify goblet cells. Serial sections were pretreated with a-amylase
(239 mg/ml for 1 hr at 37uC: Worthington Biochemical Corpo-
ration) to test for glycogen contribution to the PAS staining. For
IHC, paraformaldehyde fixed serial sections were deparaffinized,
rehydrated and antigens were retrieved in 10 mM citrate, pH 6.0,
using a 2100 Retriever pressure cooker (PickCell Laboratories).
Proteinase K digestion (20 mg/ml in 50 mM Tris base, pH 8.0,
0.1 mM EDTA, 0.5% Triton X- 100 at 37uC for 10 min) was
used for antigen retrieval for the lysozyme antibody. Samples were
processed using the Histostain Plus LAB SA Detection System
(Invitrogen) according to the manufacturer’s instructions using the
antibodies listed above. Stained slides were counterstained briefly
in Mayer’s hematoxylin (Sigma) and photographed using a Leica
DM 4000B microscope (Leica-microsystems) with Adobe Photo-
shop image capture software (Adobe).
Detection of Paneth cell zinc
Paneth cell labile zinc was detected using the zinc-specific-
responsive fluorescent dye Zinpyr-1(ZP1) (Millitech) essentially as
described with modifications [26]. The small intestine from 3 to 5
mice per group was isolated, flushed with cold PBS and cut into
small pieces that were dropped into cold 0.6 M sucrose in PBS.
Once the small intestine pieces sank (1 to 2 min) they were
transferred to a solution of 2 parts 0.6 M sucrose plus 1 part TFM
embedding compound (Triangle Biomedical Sciences, Inc.) until
they sank (2 to 3 min). The intestine pieces were then immersed in
TFM, frozen in dry ice-propanol and 6 mm frozen sections were
cut. Frozen sections were thawed for ,30 seconds at room
temperature in a solution containing 20 mM ZP1 and 0.5 mM
DAPI in 147 mM NaCl, 4 mM KCl, 3 mM CaCl2, 0.9 mM
MgCl2, 11 mM HEPES, pH 7.4, and 10 mM glucose, washed
briefly in PBS and then photographed using a Leica DM 4000B
microscope (Leica-microsystems) with Adobe Photoshop image
capture software (Adobe). ZP1 was visualized using the +L5
(Leica-microsystems) GFP filter cube and DAPI stained nuclei
were visualized using the +A4 filter cube (Leica-microsystems).
Brightness of the photographs was reduced in Photoshop.
Western blot analysis
Liver proteins were isolated by homogenizing ,100 mg of
tissue in 400 ml of RIPA buffer (150 mM NaCl, 50 mM Tris base,
pH 8.0, 1% NP40, 0.5% deoxycholate, 0.1% SDS, plus Complete
Protease Inhibitor Cocktail and PhosStop phosphatase inhibitor
cocktail (Roche Applied Science). Tissues were homogenized at
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then centrifuged at 10,0006g for 10 min at 4uC, the supernatant
was collected and protein concentration was determined using
BCA reagent (Pierce Biotech). Proteins (30 mg) were resolved on
7.5% or 10% SDS-polyacrylamide gels and transferred to
polyvinylidene difluoride membranes (Life Science Products,
Inc.) using a Transblot semi-dry transfer apparatus (BioRad)
according to the manufacturer’s instructions. Membranes were
blocked overnight in 5% milk in PBS-T or 5% BSA in PBS-T as
suggested by the antibody source and then incubated with primary
antibody in blocking solution at the appropriate dilution for 2 h at
room temperature. After extensive washing, membranes were
incubated with goat anti-rabbit horseradish peroxidase-conjugated
secondary antibody (1:2000) and the blot was developed using
ECL Plus reagent (Amersham Biosciences) according to manu-
facturer’s instructions and detected using Kodak BioMax MS film
(Kodak).
Elemental and essential metal determination
Elemental profiling via inductively coupled plasma mass
spectrometry (ICP-MS) was performed at the Purdue University
Ionomics Facility, Purdue University, West Lafayette, Indiana as
described previously [21]. The following elements were measured:
Na, Mg, P, K, Ca, Fe, Co, Cu, Zn, Mn, As, Se, and Mo. Mouse
tissues (n=5 to 10: ,100 mg wet weight each sample) were dried
at 95uC in a vacuum oven. Dried samples of about 5 to 10 mg
were weighed into Pyrex tubes and digested in 0.7 to 1.5 ml
concentrated HNO3 at 110uC for 4 h. Each sample was diluted as
optimal with 18 MOhm water and analyzed on an Elan DRCe
ICP-MS (PerkinElmer). Methane was used as a collision cell gas to
measure iron. Gallium and indium were used as internal
standards, added to the digestion acid bottle to a concentration
of 20 mgl
21. National Institute of Standards and Technology
traceable single element ICP standards (Ultrasci) were used to
make up the calibration standards. Tissue concentrations were
determined as mgg
21 dry weight (ppm) of each element.
Statistical analyses
Graphs were generated and statistical analyses performed using
GraphPad Prism5 software (GraphPad Software). Statistical
significance was determined using the Unpaired T-test (two-tailed)
and values were considered different if P,0.05. Data are
expressed as the mean 6 S.E.M. *indicates P,0.05; *** indicates
P,0.001; **** indicates P,0.0001
Supporting Information
Figure S1 The intestine Zip4 gene controls growth and viability.
(A) Neonatal mice homozygous for the floxed Zip4 gene and
positive for the vil-CreERT2 gene (Zip4 intest KO) and littermates
homozygous for the floxed Zip4 gene but negative for the vil-
CreERT2 gene (Con) were injected for 5 consecutive days with
tamoxifen beginning 5 days post-partum. After weaning on day 21
their body weights were measured daily for three days. These mice
were fed normal chow after weaning. (B) Recently weaned mice
(Zip4 intest KO and Con) were injected for 3 consecutive days with
tamoxifen and their body weight was measured daily. Every Zip4-
intestine KO mouse examined died within 16 days of initiation of
the knockout. (C) Recently weaned mice (Zip4 intest KO and Con)
were given a single injection of tamoxifen and their body weights
were measured daily for 26 days.
(TIF)
Figure S2 Intestine-specific deletion of Zip4 does not apparently
cause a rapid change the distribution or abundance of goblet and
enteroendocrine cells in the villi of the small intestine. Recently
weaned mice were injected 3 consecutive days with tamoxifen and
the small intestines from Zip4-intestine knockout (Zip4 intest KO)
mice (5 mice per group) were harvested on the indicated days after
initiation of the knockout. Paraffin sections of small intestine were
processed for IHC using an antibody against mouse Sox9 (Sox9).
Brown color indicates positive immunostaining. An arrow points
to Sox9 positive enteroendocrine cells interspersed among the
villus enterocytes. Serial sections were also stained with PAS to
detected mucin positive goblet cells. Dark pink to red color
indicates positive PAS staining. An arrow points to mucin positive
goblet cells interspersed among the villus enterocytes.
(TIF)
Table S1 List of oligonucleotides used for integration screening
in embryonic stem cells and genotyping of Zip4 alleles in mice.
(DOCX)
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